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http:WHAT THIS PAPER ADDS
This was a commissioned topical review on the risk assessment of, and being unﬁt for surgery.The concept of risk assessment and the identiﬁcation of surgical unﬁtness for vascular intervention is a
particularly controversial issue today as the minimally invasive surgical population has increased not only in
volume but also in complexity (comorbidity proﬁle) and age, requiring an improved pre-operative selection and
deﬁnition of high risk. A practical step by step (three steps, two points for each) approach for surgical risk
assessment is suggested in this review. As a general rule, the identiﬁcation of a “high risk” patient for vascular
surgery follows a step by step process where the risk is clearly deﬁned, quantiﬁed (when too “high”?), and
thereby stratiﬁed based on the procedure, the patient, and the hospital, with the aid of predictive risk scores.
However, there is no standardized, updated, and objective deﬁnition for surgical unﬁtness today. The major gap in
the current literature on the deﬁnition of high risk in vascular patients explains the lack of sound validated
predictive systems and limited generalizability of risk scores in vascular surgery. In addition, the concept of ﬁtness
is an evolving tool and many traditional high risk criteria and deﬁnitions are no longer valid. Given the preventive
purpose of most vascular procedures performed in elderly asymptomatic patients, the decision to pursue or
withhold surgery requires realistic estimates not only regarding individual peri-operative mortality, but also life
expectancy, healthcare priorities, and the patient’s primary goals, such as prolongation of life versus maintenance
of independence or symptom relief. The overall “frailty” and geriatric risk burden, such as cognitive, functional,
social, and nutritional status, are variables that should be also included in the analyses for stratiﬁcation of surgical
risk in elderly vascular patients.
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The concept of risk assessment and the identiﬁcation of
surgical unﬁtness for vascular intervention is a particularly
controversial, debated, and challenging issue. Complications
after surgical procedures are associated with a signiﬁcant
increase in mortality, prolonged intensive care and hospitalceased.
rresponding author. Cardiovascular Surgery Department, University
l (CHU, ULg) of Liège, CHU Sart Tilman B35, 4000 Liege, Belgium.
il address: philippe.kolh@chu.ulg.ac.be (P. Kolh).
-5884/ 2016 European Society for Vascular Surgery. Published by
r Ltd. All rights reserved.
//dx.doi.org/10.1016/j.ejvs.2016.02.004lengths of stay, and marked increases in overall hospital
costs. In the current cost-constrained healthcare environ-
ment, where the value of operative interventions is deter-
mined by outcomes, accurate assessment of operative risk
is an important goal to guide clinical decision making. Now
more than ever, the potential beneﬁts associated with
vascular surgery need to be balanced with alternative,
mostly less invasive, strategies with lower risk exposure.1
In recent decades, the implementation of these new less
invasive endovascular alternatives has modiﬁed the risk
proﬁle of vascular interventions. In addition, improvements
in anesthetic care and the availability of modern cardio-
pulmonary assistance tools, have allowed for a lower peri-
operative burden with a decreased need for prolonged
inpatient hospitalization. Finally, the systematic use of
newer classes of medications such as statins and anti-
platelet drugs have enhanced the durability of patency after
858 P. Kolh et al.vascular procedures and decreased the peri-operative risk
of mortality and major adverse ischemic events.
Nevertheless, major concerns over patient safety still
remain. Indeed, the minimally invasive surgical population
has increased not only in volume but also in comorbidity
proﬁle and age. Therefore, improved pre-operative selection
and deﬁnition of high risk are warranted.2 Particularly for
vascular surgery the individualized surgical risk/beneﬁt
assessment is challenging. This is because most vascular
procedures mainly target prevention (e.g. prevention of
stroke from carotid stenosis, death from aneurysm rupture,
amputation from lower limb disease, etc.) and do not pri-
marily provide an effective causal treatment for the un-
derlying pathology of atherosclerosis.
Proper patient selection for vascular interventions is
based on consideration of the complex interaction of pa-
tient speciﬁc variables, and procedure and operator related
covariates. These insights should aim to assess the individ-
ual patient’s peri-operative outcome in the context of his
current life expectancy.
Even though a number of general “risk factors” of poor
peri-operative outcome are well known, the complexity of
the interaction among different factors makes it difﬁcult to
determine the exact individual risk estimation. This is
underscored by a large proportion of the adverse events
occurring in only a small proportion of high risk patients
who can be readily identiﬁed pre-operatively.3,4 Therefore,
grouping of patients into “surgically ﬁt” and “unﬁt” cate-
gories also remains largely subjective3e5 because constantly
evolving new technologies and economic interests poten-
tially inﬂuence the selection strategy.1
RISK DEFINITION AND ASSESSMENT
As a general rule, there are three main components in the
identiﬁcation of high risk surgery. The ﬁrst relates to the
type of surgery, the second to the characteristics deter-
mining the physiological ﬁtness of the patient, and the third
to the technical circumstances in which the surgery needs
to be performed. For instance, a situation of “adverse
anatomy” (carotid restenosis, abdominal re-intervention,
consequences of radiation therapy, etc.) can signiﬁcantly
alter the risk of the surgical procedure, regardless of the
physiological ﬁtness. As an additional component, in the
current endovascular era, the institutional caseload/expe-
rience can affect the level of surgical risk expected in a
vascular patient.
A practical step by step (three steps, two points for each)
approach for surgical risk assessment is proposed.First step: qualitative and quantitative deﬁnitions of
operative risk
Goal directed deﬁnitions of surgical risk. The deﬁnition of
surgical risk is a complex and sometimes controversial issue
because of the subjective nature of elements in the
assessment. These include diversity in the persons who
evaluate the risk, the outcome measurement on which the
risk is measured (risk of mortality, morbidity, cardiovascularcomplications), and the speciﬁc settings (populations, hos-
pitals, procedures) for which the risk is assumed.6a) Persons evaluating peri-operative risk. An objective
and standardized deﬁnition of high risk is challenging
because of different risk perceptions depending on
previous experiences and expectations. There has
been much speculation on the interaction between
surgery and “risk” depending on who is making the
assessment. As observed by Boyd, the patient, the
family, the anesthesiologist, the surgeon, and the
intensive care specialist all assume different
priorities in deﬁning the risk.6 For a patient, risk can
be measured as the ability to return to work or the
possibility of disability, while for the anesthesiologist
and the surgeon the risk of a procedure most likely
implies the likelihood of an uneventful operative
procedure and the possibility of peri-operative
complications.
b) Variables for outcome assessment. The comparison
of risks among different studies reporting on high risk
surgical patients is problematic because different
outcome variables (e.g., peri-operative mortality,
peri-operative morbidity, mid-term survival, etc.) are
reported as measures of risk. Mortality and cardiac
events (major adverse clinical event, as a
combination or mortality and myocardial infarction)
are the most common outcome measures used to
stratify categories of peri-operative risk and tend to
be applicable to wider groups of operative
procedures. However, assessment of peri-operative
risk also depends on the speciﬁc surgical exposure.
For instance, for a carotid procedure, assessment of
peri-operative risk will primarily look at the
incidence of peri-operative stroke and only in the
second instance at myocardial infarction and death.
In this particular instance, the concept of high risk
would relate in the ﬁrst instance to the probability
of an excess exposure to stroke. For abdominal
aortic aneurysm (AAA) procedures on the other
hand, the main risks are related to the
cardiopulmonary impact and related mortality, and
less to the post-operative incidence of stroke. For
peripheral artery disease procedures the risk of limb
loss is still another priority of different order in the
risk assessment. Finally, it should be underlined that
only a minority of the peri-operative mortality may
be related to cardiac events. In a recent study in
vascular surgery patients undergoing infrarenal
aortic replacement, only 28% of the observed
deaths were associated with post-operative
myocardial infarction and only 2% of peri-operative
deaths could be attributed solely to myocardial
infarction.7 These data strongly suggest that peri-
operative risk assessment should not focus solely on
cardiac risk assessment.
c) Settings. Risk deﬁnition is also estimated differently
depending on the type of intervention, the type of
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Improvements in the level of care have resulted in a
substantial decrease in accepted peri-operative risk,
even in the context of older age and higher
comorbidity of the treated population. Furthermore,
the hospital/institutional caseload and experience
can affect the level of surgical risk offered to a
vascular patient today. The centralization of vascular
services to provide the best care with the lowest
risks has cost implications (availability,
transportation, etc.) and provokes ethical concerns
for the individual surgeon, remaining an issue under
debate.Surgical risk quantiﬁcation. The cutoff between patients
assessed as being at “high risk” and those at “lower risk” is
not standardized and risk quantiﬁcation is difﬁcult to deﬁne
and compare between studies. Acceptable thresholds for
surgical risk can differ whether based on mortality or a
single complication alone or on a combination of different
outcome variables such as mortality and other outcome
measures (e.g. myocardial infarction, stroke, any major
complication, etc.). As a common rule, the broader the
combined outcome measure, the higher the acceptable
threshold of risk is set.
Easily understandable deﬁnitions suggested that high risk
would imply an individual risk of mortality as either >5% or
twice the risk of the random population undergoing the
procedure. However, in today’s practice, with improved
peri-operative care and surgical techniques, the incidence of
peri-operative mortality or major morbidity is not now ex-
pected to exceed 1%.8e10
Surgical patients for whom the probability of mortality is
greater than 20% should be considered at extremely high
risk. There is indeed little probability that any hemodynamic
optimization or other adjunctive actions will substantially
decrease the risk of peri-operative mortality impact in these
patients.Second step: assessment of risk related to the procedure
and to the patient to treat
As “high risk” is the risk to an individual patient compared
with the risk to the population or the risk of the procedure
compared with the risk of other surgical procedures as a
whole,6 peri-operative risk of complications may vary
depending on the magnitude, type, duration, or urgency of
the surgical procedure, the condition of the patient before
surgery, and the prevalence of comorbidities.
Procedure related risk. Stratiﬁcation of the risk related to
procedure differs in the current guidelines. The last Amer-
ican Heart Association (AHA) cardiovascular guidelines for
non-cardiac surgery deﬁne only two categories of proce-
dural risk: a low risk procedure with a combined risk of a
major adverse cardiac event (MACE) of <1% (such as
cataract or plastic surgery), while procedures with a risk of
MACE of >1% were considered at elevated risk.8 TheEuropean Society of Cardiology (ESC) and the European
Society of Anaesthesiology (ESA) guidelines use a three-arm
stratiﬁcation for surgical risk during non-cardiac surgery
with an intermediate additional category and a 5% cutoff to
differentiate procedures at intermediate from those at high
surgical risk.9,10
Open aortic and infra-inguinal procedures are both
regarded as high risk procedures, while carotid in-
terventions, either surgical (carotid endarterectomy, CEA) or
endovascular (carotid stenting, CAS), have been regarded as
low or intermediate risk procedures depending on their
application to patients with asymptomatic or symptomatic
carotid stenosis.9,10
Of note, infrainguinal revascularization, although a less
extensive intervention, entails a cardiac risk similar to, or
even higher than that of aortic procedures. This can be
explained by the higher incidence of diabetes, renal
dysfunction, ischemic heart disease, and advanced age in
this patient population. This also explains why the risk
related to peripheral artery angioplasty, which is a mini-
mally invasive procedure, is not negligible.
The extent of surgical trauma is proportionate to the
extent and duration of the intervention but also to the ur-
gency of surgery. There is general agreement that the risk is
increased in non-elective surgical repairs even though accu-
rate timing stratiﬁcation has not always been consistently
reported in studies on high risk evaluation. Individual in-
stitutions may use slightly different deﬁnitions. Guidelines
stratify surgical risk as a function of the time-sensitivity of an
intervention. An emergency procedure is one in which life or
limb is threatened if not operated within 6 hours. An urgent
procedure is deﬁned as the need for surgical intervention
between 6 and 24 hours. This allows some time for a limited
additional assessment and optimization of the patient. A
time-sensitive procedure is one which can be delayed for
>1e6weeks to allow for further evaluation and optimization
to improve outcome. An elective procedure is one in which
the procedure could be delayed for up to 1 year.8e10
Patient related risk. Patient speciﬁc factors are of critical
importance in predicting the peri-operative risk of vascular
surgical procedures. Most of the studies on high risk pa-
tients in recent decades have focused on risk stratiﬁcation
tools, incorporating multiple patient speciﬁc factors. A key
component in the pre-operative assessment of any patient
is the evaluation of the presence of active or unstable car-
diac conditions, functional capacity of the patient, and the
presence of cardiac risk factors. Determination of functional
capacity, measured in metabolic equivalents (METs) is a
simple way to provide an objective assessment of reserve
cardiac capacity. Although poor functional capacity, deﬁned
as less than 4 METs (the inability to climb two ﬂights of
stairs or run a short distance) has been associated with
increased probability of mortality especially after thoracic
surgery, this was not consistently reported in studies after
non-cardiac surgery. Poor functional capacity remains a
general predictor of poorer prognosis, but may on its own
be an insufﬁcient argument to refuse or postpone surgery.
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evidence (predictive risk models)
Risk stratiﬁcation tools are usually developed using multi-
variate analysis of multiple risk factors for a speciﬁc
outcome and may be differently established as “risk pre-
diction models” or “risk scores/indices”.11,12 Risk prediction
models estimate an individual probability of risk by entering
the patient’s data into a multivariate risk prediction model
and may be more accurate predictors of an individual pa-
tient’s risk than risk scores. Nevertheless, prediction models
are quite complex to use in the day to day clinical setting.
Risk scores have the advantage that they are simple to use
in the clinical setting allowing scoring of a patient on a
scale. Risk scores assign a weight to factors identiﬁed as
independent predictors of an outcome with the weight for
each factor often determined by the value of the regression
coefﬁcient in the multivariate analysis. The sum of the
weights in the risk score then reﬂects the degree of risk.
This system helps in deﬁning and differentiating the “high
risk” from the “low risk” patient based on stratiﬁcation
scale. However, scores do not provide an estimate for an
individual patient’s outcome.
Since investigators have progressively identiﬁed novel
pre-operative, intra-operative, or post-operative potential
predictors of surgical outcome, a multitude of scoring sys-
tems are now available to determine medical ﬁtness status
for surgery. These include “general” or “speciﬁc” score
models but it should be acknowledged that many of these
systems have become increasingly complex.
Generic risk models. “Generalized” risk prediction models
were developed to stratify surgical patients with respect to
peri-operative risk regardless of the type of surgery. One of
the most widely accepted scores is the American Society for
Anesthesiology Physical Status (ASA-PS) Classiﬁcation. This
generalized scoring system stratiﬁes patients into categories
based on their comorbidities and the subsequent risk to
their everyday life to establish how ﬁt they are to undergo
an operation.12 However, despite the proven ability in
identifying patients at much higher risk than those in the
general population, poor inter-rater reliability leading to
some subjective interpretation makes the ASA-PS derived
score less robust to use when applied outside anesthesiol-
ogist settings. In addition, it does not include a speciﬁc
surgery related risk assessment. More complex, speciﬁc
scoring systems have greater prognostic accuracy, but often
require computerized calculation, which makes them less
applicable in daily clinical practice. Therefore, ASA-PS
scoring, although only a rough estimation, still remains
helpful in predicting global peri-operative risk based on the
patient’s physical status. The surgical risk score and Amer-
ican College of Surgeons Risk Calculator represent other
more detailed efforts to estimate the risks of surgery for a
wide range of surgical procedures across many different
specialties.5 The accuracy and discriminative ability remain
under debate.
Besides general models, more “speciﬁc” risk assessment
tools were created to predict post-operative mortality inspeciﬁc patient populations, including those undergoing
vascular surgery. Despite the variability of the models, most
of the scores have tended to focus on prediction of mor-
tality and/or adverse cardiac events, without speciﬁcally
addressing the occurrence of major morbidity that is not
related to cardiac disease. The most widely accepted tool
used to predict cardiac risk remains the Revised Cardiac Risk
Index even though there is no uniform consensus.13,14 A
recent document based on National Surgical Quality
Improvement Program (NSQIP) data suggested that the
cardiac risk calculator (including type of surgery, dependent
functional status, abnormal serum creatinine, American
Society of Anesthesiologists’ class, and increasing age)
provides a risk estimate of peri-operative myocardial
infarction or cardiac arrest with better performance than
the Revised Cardiac Index.13
A systematic review of multiple stratiﬁcations tools for
non-cardiac surgery suggested that the most promising risk
predictors were the Portsmouth-Physiology and Operative
Severity Score for the enumeration of Mortality (P-POS-
SUM) and the Surgical Risk Scale.11 Nevertheless, the
overall evidence was not sufﬁciently sound to support
generalized application of any of the models. Most such
instruments have been developed and validated in single
center studies, which unfortunately limits any assessment
of their general usefulness and reliability.
Risk models speciﬁc for vascular patients.a) Risk stratiﬁcation in elective abdominal aortic
aneurysm (AAA) repairA number of risk prediction models have been consid-
ered to determine the ﬁtness status in AAA patients. These
include the Leiden Risk Model Score, the Glasgow Aneu-
rysm Score, the Vascular Biochemistry and Haematology
Outcome Model (VBHOM), the Physiological and Operative
Severity Score for the enUmeration of Mortality (POSSUM),
the Medicare system (Medicare), and the Vascular Gover-
nance North West model (VGNW). Some models were
speciﬁcally developed to assess the peri-operative risk for
AAA repair such as the Customized Probability Index (CPI),
the British Aneurysm Repair (BAR), the Abdominal Aortic
Aneurysm Statistically Corrected Operative Risk Evaluation
(AAA SCORE), or the EVAR risk Assessment (ERA)
model.15e39
The main predictors applied and validation studies are
summarized in Table S1 (supplementary material).
Not surprisingly, there is considerable overlap in these
models and a number of patient related factors have
consistently been shown to provide poor outcome in
vascular patients with AAA. However, no risk stratiﬁcation
tool will perfectly predict outcome for patients with AAA.
Unlike cardiac surgery, where some risk prediction models
have been widely validated before acceptance and routine
application in clinical practice (e.g. EuroSCORE and more
recently EuroSCORE II), in AAA repair the sensitivity and
speciﬁcity of risk models remain ill-deﬁned and their
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this include doubts about the accuracy and applicability of
models to contemporary practice, the inability to easily
perform model calculations, and uncertainty over how such
models might inﬂuence clinical practice. Lack of use may
also be because of poor awareness among clinicians of the
available options, and concerns regarding their complexity
and accuracy. A ﬁnal explanation for the suboptimal value
of the currently available AAA models is related to the high
rate of missing data in the databases used for generating
these models.
Perhaps the major drawback limiting the applicability of
AAA surgery risk scores is the lack of vigorous model vali-
dation. Despite substantial literature on the use of score
systems to predict mortality after AAA repair, none of the
models have consistently been validated nor tested on large
populations.
Data from the recent literature on accuracy of various
predictive scores raised uncertainty and led to contradictory
conclusions. The EVAR 2 trial randomized patients who
were physically ineligible for open repair (assessed with the
modiﬁed Customized Probability Index, m-CPI) to endovas-
cular repair of abdominal aortic aneurysm (EVAR) or no
repair. No differences were found in 4 year survival but the
peri-operative mortality after EVAR was 7.8%.40,41 More
recently Lim et al. deﬁned a “high risk” group of patients
undergoing EVAR in the Veterans Administration Hospitals
using the same CPI score system of the EVAR 2 trial.31
Interestingly, this study observed no excess mortality in
the high risk group (0% high risk vs. 1.2% not high risk;
p ¼ 1.0) and early complication rates were similar in pa-
tients deﬁned at high risk and those not at high risk (4%
high risk vs. 6% not high risk; p ¼ .8). The 1, 2, and 4 year
survival rates in the high risk patients (85%, 77%, 65%) were
lower than those in low risk patients (97%, 97%, 93%;
p < .001). Of note, these rates in the high risk group were
more favorable compared with a 36% 4 year survival in the
EVAR 2 trial. Instead of the overall CPI score system, Lim
identiﬁed ﬁve more reliable prognostic indicators of post-
EVAR death: age, chronic kidney disease stages 4 and 5,
congestive heart failure, home oxygen use, and current
cancer therapy.31
The Dutch Randomized Endovascular Aneurysm Man-
agement (DREAM) trial used the Glasgow Aneurysm Score
(GAS) to predict 30 day and 2 year mortality.16 The study
showed that the optimal cutoff value that predicts peri-
operative outcomes was lower for open repair (75.5) than
for EVAR (86.5), suggesting that ﬁtter patients may beneﬁt
more from having endovascular rather than open repair.
However, 2 years post-operatively this beneﬁt for EVAR was
lost. The authors concluded that GAS was most valuable in
identifying low risk patients and not very useful for iden-
tifying high risk patients.16
Additional data from the recent literature have also
shown contradictory conclusions. Egorova et al. applied a
new scoring system in 44,630 patients, assessing several
baseline risk factors (such as renal failure with dialysis, renal
failure without dialysis, clinically signiﬁcant lower extremityischemia, patient age, heart failure, chronic liver disease,
female gender, neurological disorders, chronic pulmonary
disease, surgeon’s experience in EVAR, and hospital annual
EVAR volume).42 The authors identiﬁed a group of high risk
patients that should not be treated by EVAR because of
prohibitively high mortality even with endovascular treat-
ment. Similar results were suggested by Faizer et al., in a
study from a different database of 862 patients in whom
the Glasgow Aneurysm Score, the Modiﬁed Leiden Score,
and the Modiﬁed Comorbidity Severity Score were related
to peri-operative mortality in both open repair and endo-
vascular reconstruction.23 The study showed that for pa-
tients at low medical risk, mortality did not differ between
open repair and EVAR, whereas high risk patients derived
signiﬁcant beneﬁt from EVAR. In contrast, a study of 22,830
patients in the Medicare population using a multiple logistic
regression model to evaluate the risk prediction score for
peri-operative mortality, concluded that mortality after AAA
repair was primarily predicted by comorbidities, gender, and
age, and that these predictors had similar effects for both
methods of AAA repair.24
A large population based registry in Sweden to determine
the operative mortality and long-term survival of elective
EVAR compared with open repair in high risk patients sur-
prisingly found that elective open repair had a better
outcome. These data suggested that in a high risk cohort,
patients deemed ﬁt and suitable for open repair might have
a better long-term outcome compared with patients
deemed ﬁt and suitable for EVAR.38b) Risk stratiﬁcation in ruptured AAA (rAAA) repairData on risk stratiﬁcation in ruptured AAA repair are
scarce. In such emergencies, medical ﬁtness is not the ﬁrst
priority for the choice of treatment but instead the
anatomical feasibility for EVAR. Multiple scoring systems
have been applied, especially in Canada and England, to
speciﬁcally predict mortality in rAAA. These include the
Glasgow Aneurysm Score (GAS), the Hardman Index, the
Vancouver score, and the Edinburgh Ruptured Aneurysm
Score (ERAS).32 The most common predictors are summa-
rized in Table S2 (supplementary material). None of these
scoring systems has been shown to be generally applicable.
One of the reasons for the inconsistency of predictive
scores in rAAA is the poor applicability, because of the high
likelihood of missing the data required for score calculation
in the emergency situation.
Despite the increasing number of published studies, the
reliability, accuracy, and discriminatory ability of any of
these scores to identify higher risk patients to be refused
for surgery when presenting with a ruptured aortic aneu-
rysm, remain unclear. In a validation study by van Beek
et al., the updated GAS seemed to most accurately predict
death after intervention but it was not sufﬁciently accurate
to discriminate high risk patients. It did not identify patients
with a >95% predicted death rate to reliably support the
decision to withhold intervention.43 Recent data from the
randomized Amsterdam Acute Aneurysm Trial suggest that
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separately identiﬁed and managed, because of different
risk. The ﬁrst group consists of hemodynamically unstable
patients in whom time is very limited (13% survival after
2 hours). If surgical intervention is considered in these pa-
tients, care and logistics should be optimal to prevent dying.
The second group consists of hemodynamically stable pa-
tients in whom survival is much better (96% after
2 hours).44c) Risk stratiﬁcation in peripheral vascular diseases
repairCompared with the extensive literature on scoring tools in
the AAA population, the development of stratiﬁcation sys-
tems for patients with peripheral vascular intervention is still
at its beginning. There is a larger variability in patient pop-
ulations (peripheral disease, critical limb ischemia (CLI),
claudication, undergoing amputations, etc.), outcome mea-
sures (mortality, complications, limb salvage), and time of
assessment (peri-operative, 1 year, etc.). Importantly, in pa-
tients with peripheral disease a number of factors other than
cardiac also deﬁne the risk proﬁle of an interventional pro-
cedure. These additional risk factors for increased operative
mortality are age >80 years, dependent functional status,
and renal disease (on dialysis).45e48 Biancari et al. were the
ﬁrst group to attempt risk stratiﬁcation in patients with CLI,
with the development of the National vascular registry in
Finland (FINNVASC) score.49 (Table S3, supplementary ma-
terial).This score determined the risk of a patient undergoing
a major amputation or dying<30 days after an open surgical
revascularization. In an effort to more speciﬁcally assess risk
in this population, members of the Vascular Study Group of
New England (VSGNE) used multi-institutional surgical
outcome data to develop a targeted risk assessment tool for
cardiac risk in patients undergoing lower extremity revascu-
larization.19 Other efforts to predict outcome in this patient
population include the PREVENT (PRoject of Ex vivo vein
GRaft Engineering via Transfection) III Score, which aimed to
predict the likelihood ofmortality or amputation at 1 year.50e
53 A more comprehensive, targeted risk assessment tool to
predict 30 day major morbidity and mortality after bypass
surgery for CLI was The Comprehensive Risk Assessment for
Bypass based on the American College of Surgeons-National
Surgical Quality Improvement Program (ACS-NSQIP).54
Similar risk factors have been identiﬁed for the ﬁtness of
patients undergoing major amputation mainly provided by
studies based on ACS-NSQIP or Veterans Administration
(VA) databases.55e59 A recent study based on ACS NSQIP
data, developed a practical index system, including 11
components, with a range from 0 to 13 to predict mor-
tality in patients undergoing major amputation. A score >5
was found to be associated with a high mortality risk: the
30 day mortality increasing from 1% at a score of 1, to 10%
at a score of 5, and 38% at a score of 10.45 Different
stratiﬁcation tools recently developed for patients with
peripheral disease are summarized in Table S3 (supple-
mentary material). Nevertheless, only a few accurate andgeneralizable data are available overall. There is inconsis-
tent evidence to deﬁne a high risk category of patients
allowing for widespread application of a predictive score
to all peripheral procedures including endovascular
interventions.d) Risk stratiﬁcation in thoracic aortic repairAlthough the risk assessment in thoracic aortic surgery is
a topic of major interest, it is not easy to develop reliable
risk -stratiﬁcation algorithms for predicting mortality in
these patients. This is because the groups of patients
scheduled for this type of surgery include a variety of aortic
diseases, surgical techniques, and corresponding lesions of
the aorta. The mortality rate after open thoracic surgery has
decreased substantially during the last decades because of
improvements in techniques, and with the introduction of
hybrid or total endovascular approaches. The most common
score systems to stratify the risk in thoracic aortic surgery
rely on scores developed for open chest and cardiac surgery,
such the European System for Cardiac Operative Risk Eval-
uation (EuroSCORE) and the updated Society of Thoracic
Surgery (STS) risk calculator.60,61e) Risk stratiﬁcation in carotid stenosis interventionsDeﬁning the term “high operative risk” has proven to be
highly elusive for carotid surgery because multiple studies
used “conventional” risk criteria.62e64 Conventional criteria
of high risk CEA were developed from large historical ran-
domized carotid trials such as the North American Symp-
tomatic Carotid Endarterectomy Trial (NASCET),
Asymptomatic Carotid Atherosclerosis Study (ACAS), or the
European Carotid Surgery Trial (ECST). Multiple changes and
improvements have been achieved in carotid treatment
over the years and “historical” risks appear outdated today.
Most of the studies on risk scores for the development of
post-CEA and post-CAS stroke or death carry important
limitations.65e72 The most relevant is the failure to reliably
adjust for current disease and procedure speciﬁc variables.
At present, there are no existing validated prediction
models or objective risk scores that can be used to quantify
the risk of adverse events in patients undergoing CAS or
CEA. No speciﬁc risk factors, neither physiological nor
anatomical, have yet been identiﬁed that can provide a
clear cut deﬁnition of any absolute contraindications for
CEA or CAS in modern times.
A number of reasons make it particularly challenging to
deﬁne the concept of high risk in CEA or CAS populations.
a) Carotid interventions are categorized by guidelines
within procedures at low or intermediate risk. The
overall risk exposure is low and limited when
compared with that for peripheral or aortic surgical
procedures (“high risk procedures”).
b) Unlike the assessment of risk in aortic or peripheral
diseases, where the peri-operative risk is mainly
affected by mortality and adverse cardiac outcomes,
Risk Assessment and Being Unﬁt for Surgery 863the risk of a carotid procedure is mainly the risk of
stroke. Patient and procedure related factors
increasing the risk of stroke have a major impact in
deﬁning the concept of poor ﬁtness for carotid
intervention.
c) Also, procedures to treat carotid stenosis are among the
interventions that have beneﬁtted most from
developments in technology and medical therapy.
Indeed, the widespread use of statin, antiplatelets,
and intensive lifestyle modiﬁcation allowed for a
substantial decrease in the stroke risk for patients
with carotid disease.8,9 After the introduction of CAS,
any objective assessment of “risk” for a carotid
procedure is challenged by the speciﬁc effect of
operator experience.64 There is large variability in the
stroke risk of an endovascular carotid procedure by
center and operators, which precludes generalization
of the ﬁtness for CAS.
In summary, the concept of risk exposure in carotid
vascular procedures, including the best selection between
CEA and CAS, remains unclear and must integrate operator
experience and patient characteristics.ADDITIONAL REMARKS IN RISK ASSESSMENT FOR
VASCULAR PATIENTS: TREATMENT DENIAL AND FRAILTY
Implications of “ﬁtness” for treatment refusal
One of the major implications of the lack of a standard
deﬁnition of “medically unﬁt” for a vascular patient is the
decision on whether to refuse invasive treatment, especially
for patients with large aortic aneurysms. Given the higher
frequency of rupture in larger aneurysms, a more aggressive
surgical approach is often taken. However, in patients with
important comorbidities, operative intervention may be
delayed until aneurysm size has increased sufﬁciently to
warrant the operative risk. Still, the debate about the use of
EVAR in medically unﬁt patients continues because, to date
it is not possible to assess for individual patients, whether
the risk of future rupture outweighs the risk of the surgical
intervention.73e75 This is illustrated by the results of the
EVAR-2 trial in which no difference in survival was
found.40,41 The decision to turn down corrective treatment
may be even more challenging for the repair of a ruptured
abdominal aortic aneurysm (rAAA). Paradoxically, a refusal
of elective repair does not necessarily preclude a patient
from successful emergency repair despite the reasons for
turning down treatment being valid at the time of rupture.
However, there remains large variability among de-
partments, hospitals, and countries. A recent comparative
analysis of 11,799 patients with rAAA in England and 23,838
patients with rAAA in the USA showed that non-corrective
treatment (no open or endovascular procedure per-
formed) for rAAA was signiﬁcantly more common in En-
gland than in the USA. Patients in the USA were more than
three times as likely to be offered intervention for rAAA (OR
3.19; p < .0001).73 In the same patients, the overall in
hospital mortality was signiﬁcantly greater in England thanin the USA: 65.90% vs. 53.05%; OR 1.5, 95% CI 1.38e1.58
(p < .0001). This difference was mainly because US hospi-
tals were less likely to manage rAAA by non-corrective
treatment and offered aneurysm repair to a signiﬁcantly
greater proportion of patients. Based on these data, a more
aggressive approach in selecting less ﬁt patients may be
justiﬁed, especially in teaching hospitals as data suggest
that the lowest mortality for rAAA is seen in hospital set-
tings with larger bed capacities and performing a greater
proportion of cases endovascularly.73
Nevertheless, the overall life expectancy, the healthcare
priorities, and primary patient goals, such as prolongation
of life versus maintenance of independence or symptom
relief are relevant priorities in assessing the beneﬁt/risk for
vascular procedures (mostly performed in asymptomatic
patients for preventive purpose). Geriatric risk factors, such
as cognitive, functional, social, and nutritional status, are
variables that should be included in the analyses for strat-
iﬁcation of surgical risk in these elderly patients. If surgery is
unlikely to satisfy patient goals and major expectations,
regardless of risk exposure and ﬁtness, pursuit of a non-
operative treatment may be better.Frailty
A ﬁnal step in the risk assessment relates to the current
changes in demographics leading to ageing populations.
Most of the pre-operative risk stratiﬁcation tools for aortic
aneurysms and other vascular procedures focus on cardiac
risk but do not take into account the “physiology reserve” of
elderly vascular patients. Age per se, seems to be respon-
sible for only a small increase in the risk of complications,
while cardiovascular, pulmonary, and renal disease are the
most common risk factors contributing to greater peri-
operative risk. In recent years an increasing number of
studies have shown that decrement in physiologic reserve
(frailty) may be associated with a reduced ability to recover
from the insults of major stresses such as surgery.
The concept of frailty reﬂects the loss of physical and
mental function and cumulative decline across multiple
systems leading to increased vulnerability. Frailty has been
found to be a strong predictor of morbidity and mortality
beyond traditional risk factors such as age per se, ASA class,
and other comorbidities.76e78 Various indices and mea-
surement tools, such as the Edmonton frailty score have
been applied to encompass the overall geriatric risk. There
is common agreement that high frailty, independent of
other risk factors, is associated with higher mortality and
morbidity of inpatients undergoing elective EVAR, open
repair of AAA,79 or peripheral vascular procedures.80,81 Pre-
operative assessment of frailty may be a useful adjunct in
the pre-operative stratiﬁcation of risk exposure and ﬁtness.
CONCLUSION
Although in recent decades substantial decreases in peri-
operative morbidity and mortality have occurred for most
vascular procedures, some vascular patients still remain at
high risk because of their physical status. Today, there is no
864 P. Kolh et al.standardized and objective deﬁnition of unﬁtness for
vascular surgery. The major gap in the current literature on
the deﬁnition of high risk in vascular patients explains the
lack of sound validated predictive systems and limited
generalizability of risk scores in vascular surgery. In addition,
the concept of ﬁtness is an evolving tool. A practical step by
step (three steps, two points for each) approach for surgical
risk assessment, as suggested, may be useful to address
these challenges.
An individualized assessment of whether potential ben-
eﬁts of an intervention may outweigh the risks allows tar-
geted optimization of treatment. Given the preventive role
of most vascular procedures in asymptomatic elderly pa-
tients, the decision to pursue or withhold surgery requires
realistic estimates not only of individual peri-operative
mortality, but also of overall life expectancy, healthcare
priorities, and primary patient goals, such as prolongation
of life versus maintenance of independence or symptom
relief. The assessment of risk exposure and ﬁtness should
allow surgery to satisfy patients’ goals and major expecta-
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